IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on February 6, 2017. The filing serves to announce the Company's financial results for the fourth quarter ended December 31, 2016. The full details of these results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the fourth quarter of 2016.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 6, 2017) for specific Q4 2016 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2016 guidance or 2017 outlook provided in the press release.
- Confirm the status of any material contracts or regulatory approvals mentioned in the full press release.